Results 111 to 120 of about 80,877 (282)
Addiction, EarlyView.Abstract Background and aims Cocaine use disorder (CUD) is an increasingly widespread concern worldwide. Various pharmacological treatments have been investigated for CUD, but their efficacy remains unclear, and none have been licensed for treatment.
Craig Paterson +13 more
wiley +1 more source
The International journal on drug policy, 2019 Background The United States is in the midst of a devastating opioid crisis, and the state of New Hampshire (NH) has been disproportionately impacted. Naloxone is an opioid overdose reversal medication that is critical for saving lives.
S. Bessen +7 more
semanticscholar +1 more source
Addiction, EarlyView.Abstract Background and aims Opioid use disorder (OUD) treatment guidelines worldwide recommend opioid agonist treatment (OAT) as a long‐term, potentially indefinite treatment for managing OUD. However, many individuals express a strong interest in eventually tapering fully off treatment.
Ruyu Yan +13 more
wiley +1 more source
Journal of addiction medicine, 2019 Objective: To assess the availability and price of naloxone as well as pharmacy staff knowledge of the standing order for naloxone in Pennsylvania pharmacies.
R. Graves +5 more
semanticscholar +1 more source
Canadian Medical Association Journal, 2018 Tina, Hu, Larry, Nijmeh, Adam, Pyle
openaire +2 more sources
Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017
JAMA Network Open, 2019 Key Points Question What is the availability of naloxone at pharmacies in Philadelphia, Pennsylvania, 3 years after the implementation of a statewide standing order in Pennsylvania allowing pharmacists to dispense naloxone without a prescription ...
Jenny S. Guadamuz +5 more
semanticscholar +1 more source
Addiction, EarlyView.Abstract Background and aims Individuals who engage in illicit or nonmedical opioid use may have elevated risk of health and social consequences, including progression to opioid use disorder (OUD). Preventive interventions to reduce this risk are lacking. This trial tested the impact of a primary care‐integrated collaborative care approach for reducing
Jennifer McNeely +23 more
wiley +1 more source
Adult naloxone administration protocol [PDF]
, 2018 A tertiary care facility in central Illinois noted an increase in inpatient opioid-related adverse events, including acute opioid withdrawal syndrome due to a higher than a necessary dose of naloxone.
Adhikari, Samuel S
core +1 more source
The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study.
PLoS ONE, 2019 BACKGROUND:Naloxone is a life-saving antidote for opioid overdoses. In June 2016, the Ontario government implemented the Ontario Naloxone Program for Pharmacies (ONPP) to enhance access to naloxone.
Beatrice Choremis +5 more
doaj +1 more source
Pulmonary Complications of Opioid Overdose Treated With Naloxone.
Annals of Emergency Medicine, 2019 STUDY OBJECTIVE We aim to determine whether administration of higher doses of naloxone for the treatment of opioid overdose is associated with increased pulmonary complications.
A. Farkas +7 more
semanticscholar +1 more source